![WE POSITIVE INVEST 2 (ARKEA CAPITAL), WILLE FINANCE and SWEN CAPITAL complete the €8 million fundraising of Beedeez WE POSITIVE INVEST 2 (ARKEA CAPITAL), WILLE FINANCE and SWEN CAPITAL complete the €8 million fundraising of Beedeez](medias/org-1549/shared/visuel-articlealtair-65c1f832c05c3.png)
WE POSITIVE INVEST 2 (ARKEA CAPITAL), WILLE FINANCE and SWEN CAPITAL complete the €8 million fundraising of Beedeez
Published on :
06/02/2024
06
February
Feb
02
2024
Altaïr Avocats has advised a consortium of investors, WE POSITIVE INVEST 2 (ARKEA CAPITAL), WILLE FINANCE and SWEN CAPITAL, in a €8 million fundraising operation for Beedeez, a company specialising in digital education and professional training.
Founded in 2015, Beedeez's success is also based on the development of an LMS (Learning Management System) tool specifically designed to meet the training needs of teams in the field. The platform stands out for its ability to adapt to all working environments thanks to flexible teaching formats, enabling effective learning that is accessible anywhere and at any time. This approach is complemented by a pedagogy that encourages shared learning, transforming each employee into a player in his or her own training, capable of being both trainer and learner.
This €8 million fund-raising, orchestrated by a consortium of investors and consolidated by a bank loan, bears witness to the market's confidence in Beedeez's growth prospects.
The funds raised will be used to expand their training offering, accelerate their expansion in France and internationally, and will also be invested in R&D.
The parties involved in this transaction:
Altaïr Avocats was involved in the corporate aspects of the deal With Philippe Beauregard, partner and Elise Yvart, associate. The tax aspects were entrusted to Damien Hautin, partner and Clémence Bauché, associate. Issues related to commercial contracts, IP/IT and litigation were handled by Christophe Héry, partner, Mégane Boussereau, associate and Brune Dessommes, lawyer.Finally, the social aspects: were supervised by ELLIPSE AVOCATS, represented by Arnaud Pilloix, partner and Walter Gauthier, lawyer.
History
-
Dassault Systèmes acquires Amcad Engineering
Published on : 18/09/2024 18 September Sep 09 2024Deals ENAltaïr Avocats assisted Amcad Engineering, a software developer specializing...
-
QL Clean France acquires Etanchéité du Sud Ouest
Published on : 23/07/2024 23 July Jul 07 2024Deals ENAltaïr Avocats supported the consortium QL Clean France in the acquisition of...
-
Orus Energy raises €2.2 million (seed)
Published on : 12/07/2024 12 July Jul 07 2024Deals ENAltaïr Avocats advised Orus Energy, an energy flexibility platform, during it...
-
ARKEA CAPITAL (WE POSITIVE INVEST 2) and VOLNEY DÉVELOPPEMENT participate in €9 million fund-raising for QUALIRETRAITE
Published on : 04/06/2024 04 June Jun 06 2024Deals ENAltaïr Avocats advised ARKEA CAPITAL (WE POSITIVE INVEST 2) and VOLNEY DÉVELO...
-
Astem Digital acquires Deep Company
Published on : 10/04/2024 10 April Apr 04 2024Deals ENAltaïr Avocats has advised entrepreneur Cédric Baümer and the Astem Digital g...
-
RebrAIn raises 3.7 million euros to support the fight against Parkinson's disease
Published on : 05/04/2024 05 April Apr 04 2024Deals ENAltaïr Avocats advised RebrAIn, a Bordeaux-based medtech company, in their €3...
-
Transports Veynat strengthens its territorial deployment with the strategic acquisition of Transports Klein, a gateway to the international market
Published on : 29/02/2024 29 February Feb 02 2024Deals ENAltaïr Avocats has advised Transports Veynat, the French leader in the transp...
-
WE POSITIVE INVEST 2 (ARKEA CAPITAL), WILLE FINANCE and SWEN CAPITAL complete the €8 million fundraising of Beedeez
Published on : 06/02/2024 06 February Feb 02 2024Deals ENAltaïr Avocats has advised a consortium of investors, WE POSITIVE INVEST 2 (A...
-
HEPHAISTOS-Pharma raises €2 million (seed) to accelerate the development of their ONCO-Boost treatment
Published on : 31/01/2024 31 January Jan 01 2024Deals ENAltaïr Avocats has advised HEPHAISTOS-Pharma, a key player in the biotechnolo...